{
  "id": 12137854,
  "title": "Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine",
  "url": "https://urgent.news/2026/10/05/psyence-biomed-partners-with-dea-registered-benuvia-operations-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-05T11:03:44.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/psyence-biomed-partners-with-dea-registered-benuvia-operations-to-establish-u-s-manufacture-of-pharmaceutical-grade-ibogaine"
  },
  "original_language": "en",
  "account": null,
  "summary": "Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S. development program HIGHLIGHTS Texas Ibogaine Research Corporation (“TIRC”), the wholly-owned Texas subsidiary of Psyence BioMed, enters manufacturing partnership with Benuvia Operations, LLC for the planned U.S. manufacture of pharmaceutical-grade ibogaine…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}